FDA Raps Sunovion Pharma For Bogus Benefit Claims
A print advertisement for Sunovion Pharmaceuticals Inc.'s anti-seizure drug Aptiom improperly suggests that the medication can reduce feelings of isolation that patients experience, according to a disciplinary letter released Wednesday by...To view the full article, register now.
Already a subscriber? Click here to view full article